News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|February 11, 2017

The Unmet Needs of Patients with GI Cancer

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Stage 3 colon cancer patients who tested MRD+ with Signatera after surgery saw a meaningful survival benefit from Celebrex and chemo: © stock.adobe.com.

This Test Helped Identify Treatment in Colorectal Cancer Surgery

ByRyan Scott
December 19th 2025
Dan, a pancreatic cancer survivor

Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path

BySpencer Feldman
December 18th 2025
Dr. Eileen M. O'Reilly

SHARON Trial Offers a Potential Approach for Advanced Pancreatic Cancer

ByRyan Scott
December 16th 2025
The FDA granted fast track status to muzastotug plus Keytruda for adults with microsatellite stable metastatic colorectal cancer without liver metastases: © stock.adobe.com.

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

BySpencer Feldman
December 16th 2025
Dan, a pancreatic cancer survivor

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

ByRyan Scott
December 10th 2025
Advertisement
Advertisement

Trending on CURE

1

Stigmas Faced by Patients With Lung Cancer

2

Reading the Fine Print: Why Ingredient Awareness Matters After Cancer

3

Gedatolisib Plus Faslodex Shows Efficacy in Advanced HR+ Breast Cancer

4

Addressing Concerns on Diet During Breast Cancer Treatment

5

Piqray Plus Faslodex Improves PFS in Advanced Breast Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.